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Abstract 
Objective:  This study aimed to investigate the reliability and validity of a self-administered 
version of DEMQOL-Proxy, a disease specific instrument that measures health-related 
quality of life (HRQL) in people with dementia. 
Methods:  The sample consisted of 173 informal carers of people with dementia, aged 29 to 
89 years old.  Carers were mostly female, White/White British and closely related to the 
patient.  They completed DEMQOL-Proxy (self-administered), the EQ-5D-3L (proxy-
reported about the person with dementia), EQ-5D-3L (self-reported about their own health) 
and the Zarit Carer Burden Index (ZBI).  Using well-established methods from Classical Test 
Theory we evaluated scale level acceptability, reliability and convergent, discriminant and 
known-groups validity of DEMQOL-Proxy. 
Results:  DEMQOL-Proxy (self-administered) showed high acceptability (3.5% missing data 
and 0% scores at floor or ceiling), high internal consistency reliability (α = 0.93) and good 
convergent and discriminant validity. Amongst others, we found a moderately high 
correlation with EQ-5D-3L Proxy-reported (r = 0.52) and low to essentially zero correlations 
with EQ-5D-3L Self-reported (r = 0.20) and carer and patient background variables (r ≤ 
0.20).  As predicted, DEMQOL-Proxy (self-administered) showed a modest correlation with 
DEMQOL (r = 0.32).  Known-groups differences on HRQL (comparing people with versus 
people without cognitive impairment) were of moderate effect size (d = 0.38) and in the 
expected direction. 
Conclusions:  DEMQOL-Proxy (self-administered) has comparable acceptability, reliability 
and validity with DEMQOL-Proxy (interviewer-administered).  DEMQOL-Proxy (self-
administered) can be used in a wider variety of contexts than its interviewer-administered 
version, including routine use in busy clinics.  
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Introduction 
Patient-reported outcome measures (PROMs) are well established in clinical trials and health 
services research as important ways of measuring patients’ perceptions and understanding of 
their health condition and treatment (e.g. Browne et al., 2008; Dawson et al., 2010).  The 
Department of Health (England) is also committed to ensuring that assessing the outcome of 
care takes into account the views of patients and, where relevant, their lay carers (Black, 
2013).  PROMs are routinely collected for four areas of elective operations (hip and knee 
replacement, varicose surgery and hernia repair) in England and development studies have 
been or are being conducted for a number of more long term conditions, including dementia 
(National PROMs Programme – http://www.hscic.gov.uk/).   
DEMQOL and DEMQOL-Proxy (Smith et al., 2005a, 2005b, 2007) are disease 
specific instruments that measure important aspects of health-related quality of life (HRQL) 
in people with dementia.  DEMQOL is self-reported by the person with dementia and 
DEMQOL-Proxy is reported by their family (informal) carer on behalf of the person with 
dementia.  Both instruments are interviewer administered according to a standard manual and 
were developed to be used together to provide complementary perspectives; DEMQOL-
Proxy was not intended as a substitute for the reports of the person with dementia but is a 
practical alternative in later stages of the condition when self-report may no longer be 
possible.  There is reported evidence of reliability and validity for both instruments in people 
with mild or moderate dementia.  Furthermore, although the evidence is based on a small 
sample, DEMQOL-Proxy is also promising with people with severe dementia (Smith et al., 
2005a, 2007).  Recently, Mulhern et al. (2013) developed disease-specific utility scores for 
DEMQOL and DEMQOL-Proxy.  The two instruments are widely used in research and are 
currently being considered for routine use by the Department of Health (England) 
(Department of Health, 2014, p. 37).   
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The practicality of using DEMQOL-Proxy in routine contexts may be limited by the 
need for interviewer administration.  This form of administration was originally deemed 
necessary as many family carers were themselves elderly, but it is time consuming and labour 
intensive.  In this paper, we present the psychometric evaluation of DEMQOL-Proxy (self-
administered), an instrument that is still intended to be used alongside DEMQOL, but the 
simpler administration method is likely to be more feasible for use in routine settings.  
Although so-called “modern” psychometric methods are increasingly used in the 
development of health outcome measures and have many advantages, we used classical 
psychometric methods to investigate acceptability, reliability and validity of DEMQOL-
Proxy (self-administered).  This was because we sought to compare the self-administered 
version of DEMQOL-Proxy with the original interviewer administered version using the 
same methods of analysis.   
 
Methods 
Participants 
As part of the pilot phase of a large study evaluating Memory Assessment Services (MAS) 
we recruited 173 informal carers of people with dementia who were attending one of four 
MAS (Barnet, Enfield and Haringey; West London; Humber; and South West Yorkshire) for 
a first referral for suspected dementia and who had agreed to be part of the study.  Patients 
who had insufficient English language to be able to understand the consent process or 
complete the questionnaires were excluded (as were their carers). Sample characteristics are 
presented in Table 1.  Carers were mostly female, White/White British and were the patient’s 
partner (husband/wife/partner) or their son or daughter.  Carers ranged in age from 29 to 89 
years (mean = 62, SD = 14).  We categorised disease severity based on patients’ scores on the 
Mini-Mental State Examination (MMSE; Folstein et al., 1975), using a cut point of < 24 (or 
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an equivalent published cut-off score if a different measure was used) to indicate the presence 
of cognitive impairment (Tombaugh and McIntyre, 1992).  Based on this categorisation, 56% 
of the carers cared for a patient with cognitive impairment and 33% cared for a patient with 
no cognitive impairment; for 11% of the carers cognitive impairment level of the patient they 
cared for is unknown. 
[Insert Table 1 about here] 
Procedure 
Patients and their carers were sent an invitation letter introducing the study with their clinic 
appointment letter.  Written, informed consent was obtained from both the patient and their 
carer at their clinic appointment (held either in the clinic or at home).  The carer was asked to 
complete DEMQOL-Proxy in self-administered format (i.e. carers were given the 
questionnaire booklet and asked to complete it by themselves).  All instructions to the carer 
were standardised, i.e. in written format in the questionnaire only.  No additional instructions 
were provided except for asking the carer to read the written instructions and complete the 
questionnaire without consulting the patient.  In addition to DEMQOL-Proxy, carers also 
completed the EQ-5D (proxy-reported about the person with dementia and also self-reported 
about their own health) and the Zarit Carer Burden Index (see Instruments below).  
Afterwards patients were asked to complete DEMQOL, using the usual interviewer 
administered format.  Ethical approval was obtained from the National Research Ethics 
Service Committee London - Queen Square (REC Reference Number: 14/LO/1146). 
 
Instruments 
DEMQOL-Proxy. DEMQOL-Proxy (Smith et al., 2005a, 2005b, 2007) consists of 
31 questions each assessed on a 4-point response scale: a lot, quite a bit, a little, not at all.  
The questions were derived from five conceptual domains: health and well-being (12 
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questions), cognitive functioning (9 questions), daily activities (6 questions), social 
relationships (2 questions) and self-concept (2 questions).  There is also an additional overall 
quality of life question, answered on a 4-point scale: very good, good, fair, poor.  The items 
are scored according to a standard scoring algorithm (http://www.bsms.ac.uk/research/our-
researchers/sube-banerjee/demqol/) to produce an overall score where higher scores represent 
better HRQL.   
EQ-5D-3L.  The EQ-5D (Brooks, 1996; The EuroQol Group, 1990) is a generic 
measure of health utility, that is widely used to evaluate patient-reported health outcome in 
routine contexts.  It was therefore included in this study as a validating measure for 
DEMQOL-Proxy and so as to be able to compare the results with similar studies.  The EQ-
5D includes one question on each of 5 domains: mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression and also a visual analogue scale represented by a 
thermometer running from 0 (worst imaginable health state) to 100 (best imaginable health 
state).  Each of the 5 descriptive questions has its own 3-point response scale.  Carers 
completed the EQ-5D about their own health and also as a proxy-report about the person with 
dementia (where they were asked to give the answer they thought the patient would give).  
We used the UK TTO based index values (Dolan, 1997; MVH Group, 1995). 
Zarit Burden Interview (ZBI).  The short version of the Zarit Burden Interview 
consists of 12 items that assess carer burden (Bédard et al., 2001).  All of the questions are 
reported on a 5-point Likert-type response scale: 0 (never), 1 (rarely), 2 (sometimes), 3 (quite 
frequently) or 4 (nearly always).  Item scores are summed to create an overall score where 
higher scores represent more carer burden.  Additionally, two subscale scores can be created: 
Personal Strain (items 1 to 9) and Role Strain (item 10 to 12). Because we made one minor 
change to the wording of the questionnaire (changing the word “relative” to “relative/friend” 
to allow for the possibility that carers may not be family members), we checked whether we 
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replicated this two-dimensional structure in our data set; details can be obtained from the first 
author.  Internal consistency reliability Cronbach’s α was high (Total score: 0.93, Personal 
Strain: 0.94, Role Strain: 0.83). We concluded our re-worded version of the short version of 
the ZBI to be appropriate for use in this study.   
 
Psychometric analyses 
The psychometric analyses aimed to replicate the psychometric evaluation undertaken on the 
original interviewer-administered version of DEMQOL-Proxy (Smith et al., 2005a).  This 
was based on well-established methods from Classical Test Theory (CTT) (Nunnally and 
Bernstein, 1994; Scientific Advisory Committee of the Medical Outcomes Trust, 2002; US 
Food and Drug Administration, 2009) and evaluated its scale level acceptability, reliability 
and validity.  Where possible we used the same validity hypotheses as were used to evaluate 
the original interviewer-administered form of DEMQOL-Proxy, though in some instances 
these have been adapted as the present study did not include other dementia-specific HRQL 
instruments and also used a different generic measure (EQ-5D instead of the SF-12). 
Acceptability and Data Quality.  Acceptability refers to completeness of the data, 
i.e. the proportion of the sample for whom an overall score on DEMQOL-Proxy can be 
computed. To obtain scores we applied the instrument’s standardised scoring algorithm, 
which means that for cases with less than 50% missing item scores, missing values were 
replaced by the person specific mean across completed items. Data quality refers to the 
overall score having sufficient variance and no large floor and ceiling effects (large 
proportions of the sample with lowest/highest overall score preventing measuring 
deterioration/improvement). The criterion for acceptability was < 5% missing data for the 
overall score, the criterion for data quality was floor and ceiling effects ≤ 15% (cf. Lim et al., 
2015).   
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Reliability (Internal Consistency).  Internal consistency reliability indicates the 
extent to which the items have something in common and each item contributes positively to 
the overall scale. It was evaluated using Cronbach’s alpha (Cronbach, 1951) (criterion: α ≥ 
0.7).   
Convergent Validity.  Convergent validity is the extent to which a construct is 
correlated with measures of the same or similar constructs.  We examined convergent validity 
of DEMQOL-Proxy (self-administered) in three ways: Firstly, we examined the correlation 
between DEMQOL-Proxy (self-administered) and DEMQOL.  Like DEMQOL, DEMQOL-
Proxy purports to assess the patient’s HRQL, however the strength of the association between 
these two scales is known to be modest (Smith et al., 2005b). Based on findings with the 
interviewer administered version of DEMQOL-Proxy (Smith et al., 2005a), we expected a 
correlation of 0.3 to 0.4. Secondly, we examined the relationship between DEMQOL-Proxy 
(self-administered) and the EQ-5D.  We expected a moderate positive correlation in the 
region of 0.3-0.5 between these two instruments (as one is disease specific and the other is 
generic so the strength of relationship may be reduced).  Thirdly, we examined the 
relationship between DEMQOL-Proxy (self-administered) and the ZBI (short version).  We 
hypothesised that higher carer burden would be associated with lower HRQL of the person 
with dementia, however only moderately (in the region of 0.3-0.5), as these are similar but 
different constructs.   
Discriminant Validity.  Discriminant validity is the extent to which a construct is 
uncorrelated with measures of different constructs.  We examined discriminant validity by 
comparing DEMQOL-Proxy (self-administered) with the EQ-5D ratings that the carers made 
about themselves.  We hypothesised that DEMQOL-Proxy should not be correlated with the 
carer’s own health.  We also examined the association between DEMQOL-Proxy and both 
carer’s background variables (age, gender, number of years acquainted, hours spent with the 
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patient in the last week) and patient characteristics (age and gender); we hypothesised no 
associations.   
Known Groups Validity.  Known-groups validity is the extent to which the construct 
shows expected differences between groups that are known to be different.  Little is known 
about the natural history of HRQL in dementia and how it is expected to change with 
increasing severity, though there is some evidence, based on small samples for differences 
between mild/moderate and severe (Smith et al. 2005a).  As very few of our sample had 
severe cognitive impairment, we investigated the hypothesis that people without cognitive 
impairment (MMSE score ≥ 24) would have higher DEMQOL-Proxy scores than people with 
cognitive impairment (MMSE score < 24).  Effect size was assessed by Cohen’s d (Cohen, 
2009). 
 
Results  
Acceptability and Data Quality 
Table 2 provides information on acceptability and data quality. Acceptability was high for 
DEMQOL-Proxy (self-administered).  There were only a small number of missing scores 
(3.5%), though in part this reflects the imputation rule that is part of the scoring algorithm for 
DEMQOL-Proxy, and there were no floor or ceiling effects.  DEMQOL-Proxy scores ranged 
from 38 to 123 (mean = 86.3, SD = 16.1).  The distribution of DEMQOL-Proxy total score 
appeared slightly skewed to the left (-0.47), with the mass of the distribution concentrated 
above the mean (median = 89). 
 [Insert Table 2 about here] 
Reliability (Internal Consistency) 
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DEMQOL-Proxy (self-administered) had high internal consistency (Cronbach’s  = 0.93, N 
= 167), slightly higher than in the original development for the interviewer-administered 
version of DEMQOL-Proxy ( = 0.89; Smith et al., 2005a, p. 54).  
 
Convergent validity 
The association between DEMQOL-Proxy (self-administered) and DEMQOL was 0.32, in 
agreement with expectations. Furthermore, as hypothesised, DEMQOL-Proxy (self-
administered) showed a moderately high positive association with carer's proxy rating of 
HRQL on the EQ-5D (r = 0.52).  In addition, DEMQOL-Proxy (self-administered) showed a 
weaker negative correlation with ZBI (r = -0.41 to r = -0.46), although the association was 
slightly stronger than expected. See Table 3 for the convergent (and discriminant) 
correlations. 
[Insert Table 3 about here] 
Discriminant validity 
We found a weak, positive association between DEMQOL-Proxy (self-administered) and 
carer’s self-rating on the EQ-5D (r = 0.20), see Table 3.  The difference with the convergent 
correlation of DEMQOL-Proxy (self-administered) with carer’s proxy-rating on the EQ-5D (r 
= 0.52) is statistically significant, z = 3.58, p < 0.001 (Lee and Preacher, 2013; Steiger, 1980). 
Furthermore, we found a weak correlation with carer’s age (r = 0.20); all other associations 
of DEMQOL-Proxy (self-administered) with background variables of carer and patient were 
essentially zero (Table 3).  We found no statistically significant differences in DEMQOL-
Proxy (self-administered) total score for male and female carers, mean = 85.8 (SD = 15.7), n 
= 51 and mean = 86.4 (SD = 16.0), n = 113, respectively, t(162) = -0.21, p = 0.82 
(two-tailed), effect size = 0.04.  Likewise, we found no statistically significant differences in 
DEMQOL-Proxy (self-administered) total score for male and female patients, mean = 87.6 
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(SD = 16.5), n = 76 and mean = 85.0 (SD = 15.3), n = 88, respectively, t(162) = 1.06, p = 
0.29 (two-tailed), effect size = 0.16. 
 
Known Groups Differences 
DEMQOL-Proxy (self-administered) showed known-groups validity as, on average, people 
without cognitive impairment (mean = 89.9, SD = 14.6, n = 57) had better HRQL scores than 
people with cognitive impairment (mean = 84.0, SD = 16.6, n = 92), t(147) = 2.20, p = 0.015 
(one-tailed), effect size = 0.38 (Table 2). 
 
Discussion 
The present study aimed to investigate the reliability and validity of a self-administered 
version of DEMQOL-Proxy compared with the original interviewer administered version 
(Smith et al., 2005a, 2007). As with the original interviewer administered version we used 
CTT to investigate DEMQOL-Proxy (self-administered)’s psychometric properties. Overall, 
the results suggest that the two versions are comparable.   
As for the original version, acceptability of DEMQOL-Proxy (self-administered) was 
high (little missing data and no floor/ceiling effects).  Reliability was assessed in terms of 
internal consistency.  The high Cronbach’s alpha indicated that all of the items were 
homogenous and relating to a similar underlying construct.  Convergent validity (moderate 
association with DEMQOL, EQ-5D and three ZBI scores) and discriminant validity 
hypotheses (little or no association between DEMQOL-Proxy and carer’s own health, carer’s 
age, gender, person with dementia’s age, gender, length of time that the carer had known the 
person with dementia or the amount of time spent with them each week) were supported.  
Known-groups validity was supported by a moderate effect size between groups with and 
without cognitive impairment.   
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The results support the use of DEMQOL-Proxy as a self-administered questionnaire.  
Moreover, the analyses reported here support a more practical use of DEMQOL-Proxy and 
enable it to be used in a more flexible way.  Self-report is potentially less time consuming and 
cheaper than interviewer administration.  Given the growing interest in the use of patient 
reported outcome measures (PROMS) as part of routine monitoring of health care including 
dementia care (Department of Health, 2009), this is an important, practical development.  The 
DEMQOL system is one of the few disease-specific HRQL measures for people with 
dementia that consists of both patient and proxy report. It can therefore be used across the 
range of severity and types of dementia and across different care arrangements.  Where 
possible both patient and proxy reports should be collected; it keeps the patient’s view central 
while complementing it with the proxy’s view.  The development of DEMQOL-Proxy (self-
administered) makes the use of DEMQOL-Proxy more feasible, particularly in in busy 
clinics.   
The analyses reported here have some limitations.  We have not evaluated test-retest 
reliability as collection of these was not feasible within the design of this study.  This should 
be considered before the psychometric robustness of DEMQOL-Proxy (self-administered) 
can be confirmed.  The clinic setting (as opposed to sending questionnaires by mail) meant 
that there was a member of staff available to respond to questions if necessary.  None of the 
four sites reported that carers had difficulty completing the questionnaires, and clinic staff 
were instructed not to interpret or re-phrase questions.  However, it is possible that different 
responses to queries in different clinics could affect the reliability of DEMQOL-Proxy (self-
administered).  The results are also limited by the high ceiling effects found for the EQ-5D 
Self-rating.  We used the EQ-5D as a validating measure as it is widely used in other studies 
that have evaluated the feasibility of PROMs in routine settings.  However, the large 
proportion of the sample who scored the maximum score restricted the range and reduced 
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discrimination for EQ-5D Self-rating more than for EQ-5D Proxy-rating, which may have 
artificially attenuated the discriminant correlation.   
Finally, these analyses are also based on psychometric methods derived from CTT.  
Although these methods are well established (Scientific Advisory Committee of the Medical 
Outcomes Trust, 2002; US Food and Drug Administration. 2009), their limitations for health 
related scores have become well known over the last 10 years (Hobart and Cano, 2009).  In 
particular, the scores derived from these methods are ordinal rather than interval, they are 
specific to the particular sample in which they are derived and they can only be used at the 
group level.  We used these methods so as to first be able to compare directly with the 
analyses from the development of the original interviewer administered version of 
DEMQOL-Proxy, using the same methods.  Our current work will use modern psychometrics 
(Rasch Measurement Theory; Rasch, 1960/1980) to re-evaluate the measurement properties 
of both DEMQOL and DEMQOL-Proxy (self-administered) and to improve the scoring 
algorithms.   
Conclusions 
DEMQOL-Proxy (self-administered) has comparable acceptability, reliability and validity 
with DEMQOL-Proxy (interviewer-administered).  It is consequently feasible to use 
DEMQOL-Proxy (self-administered) in a wider variety of contexts, including routine use in 
busy clinics.  Robust use of the instrument will still depend on careful training of staff to 
ensure that its use is standardised.  This includes training staff not to interpret or re-phrase 
questions, even if they are asked.  DEMQOL-Proxy (self-administered) should be scored 
using the standard scoring algorithm to derive a single overall score 
(http://www.bsms.ac.uk/research/our-researchers/sube-banerjee/demqol/).  Where possible 
DEMQOL-Proxy (self-administered) should still be used alongside DEMQOL and the two 
instruments should be interpreted together.    
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Table 1 
Respondent Characteristics 
 Carer Patient 
 
Gender Male  52 (31.3) 78 (47.0) 
 Female 114 (68.7) 88 (53.0) 
 
Age Mean (SD) 62.0 (13.7) 78.7 (8.1) 
 Range (n) 29 – 89 (164) 52 – 93 (166) 
 
Ethnicity 
 White/White British 149 (90.9) 148 (90.2) 
 Black/Black British 1 (0.6) 1 (0.6) 
 Asian/Asian British 10 (6.1) 11 (6.7) 
 Mixed 3 (1.8) 0 (0.0) 
 Other 1 (0.6) 4 (2.4) 
 
Relationship to patient 
 Husband/wife/partner 73 (44.2) 
 Son/daughter 66 (40.0) 
 Son/daughter-in-law 13 (7.9) 
 Sibling 5 (3.0) 
 Other relative 3 (1.8) 
 Friend 3 (1.8) 
 Neighbour 1 (0.6) 
 Other 1 (0.6) 
 
Living with patient 
 Yes 87 (52.7) 
 No 78 (47.3) 
 
Years acquainted 
 Mean (SD) 49.5 (13.7) 
 Range (n) 1 – 80 (164) 
 
Days spent (last week) 
 Mean (SD) 5.2 (2.3) 
 Range (n) 0 – 7 (165) 
 
Hours spent (last week) 
 Mean (SD) 80.6 (73.6) 
 Range (n) 0 – 168 (160) 
 
Note. Unless stated otherwise, the entries are numbers followed by percentages (in parentheses). 
 
 
DEMQOL-Proxy (self-administered)        18 
 
Table 2 
Acceptability and Data Quality 
 Missing 
Scales n n (%) Scale Sample % Floor % Ceiling Mean (SD) Skew 
 
Whole samplea 
 DEMQOL Proxy 167 6 (3.5) 31 - 124 38 - 123 0.0 0.0 86.3 (16.1) -0.47 
 EQ-5D Proxy 162 11 (6.4) -0.594 - 1 -0.429 - 1 0.0 9.3 0.579 (0.303) -0.94 
 EQ-5D Self 163 10 (5.8)  -0.594 - 1 -0.594 - 1 0.6 46.0 0.806 (0.279) -2.29 
 ZBI Total score 158 15 (8.7) 0 - 48 0 - 48 6.3 0.6 13.5 (9.9) 0.94 
 ZBI Personal Strain 158 15 (8.7) 0 - 36 0 - 36 12.0 0.6 9.2 (8.0) 1.01 
 ZBI Role Strain 165 8 (4.6) 0 - 12 0 - 12 13.9 1.2 4.4 (2.9) 0.22 
 
No cognitive impairmentb 
 DEMQOL Proxy 57 0 (0.0) 31 - 124 49 - 123 0.0 0.0 89.9 (14.6) -0.38 
 EQ-5D Proxy 56 1 (1.8)  -0.594 - 1 -0.003 - 1 0.0 12.3 0.632 (0.262) -0.71 
 EQ-5D Self 53 4 (7.0)  -0.594 - 1 -0.016 - 1 0.0 47.4 0.842 (0.235) -2.29 
 ZBI Total score 52 5 (8.8) 0 - 48 0 - 38 5.3 0.0 12.5 (9.2) 0.99 
 ZBI Personal Strain 52 5 (8.8)  0 - 36 0 - 28 10.5 0.0 8.2 (7.1) 1.24 
 ZBI Role Strain 57 0 (0.0)  0 - 12 0 - 10 17.5 0.0 4.3 (3.0) 0.11 
 
Cognitive impairmentc 
 DEMQOL Proxy 92 5 (5.2) 31 - 124 38 - 111 0.0 0.0 84.0 (16.6) -0.50 
 EQ-5D Proxy 89 8 (8.2)  -0.594 - 1 -0.429 - 1 0.0 6.2 0.554 (0.317) -0.96 
 EQ-5D Self 92 5 (5.2)  -0.594 - 1 -0.594 - 1 2.6 39.2 0.778 (0.306) -2.24 
 ZBI Total score 88 9 (9.3) 0 - 48 0 - 48 5.2 1.0 13.9 (10.0) 1.00 
 ZBI Personal Strain 88 9 (9.3)  0 - 36 0 - 36 11.3 1.0 9.5 (8.2) 0.97 
 ZBI Role Strain 90 7 (7.2)  0 - 12 0 - 12 10.3 2.1 4.4 (2.8) 0.41 
 
Note.  EQ-5D: index value based on UK TTO value set (high value = good health state). ZBI-Short version Personal Strain: items 1 - 9. ZBI-Short version 
Role strain: items 10 - 12. 
a N = 173. 
b n = 57. 
c n = 97. 
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Table 3 
Convergent and Discriminant Validity of DEMQOL-Proxy (Self-Administered) 
 DEMQOL Proxy total score 
 ------------------------------------ 
 r (95% CI) 
 
Convergent Validity: 
 
DEMQOL total score 0.32 (0.16; 0.47) 
 
EQ-5D Proxy-ratinga 0.52 (0.38; 0.65) 
 
Zarit Burden Interview 
 Total score -0.46 (-0.61; -0.30) 
 Personal Strain -0.41 (-0.57; -0.24) 
 Role Strain -0.45 (-0.58; -0.28) 
 
Discriminant Validity: 
 
EQ-5D Self-ratinga 0.20 (0.02; 0.40) 
 
Carer background variables 
 Gender -0.03 (-0.19; 0.13) 
 Age 0.20 (0.05; 0.34) 
 Years acquainted 0.06 (-0.11; 0.23) 
 Hours spent (last week) 0.13 (-0.05; 0.30) 
 
Patient background variables 
 Gender -0.05 (-0.22; 0.12) 
 Age 0.08 (-0.11; 0.27) 
 
 
Note.  N = 139.  Pearson correlations and 95% CIs based on Simple Sample Method bootstrap 
analysis (case resampling with replacement from the original dataset, N = 1000). 
aIndex value based on UK TTO value set (high value = good health state). 
 
 
